The University of Chicago Header Logo

Connection

Bana Jabri to Celiac Disease

Back to Details
This is a "connection" page, showing publications Bana Jabri has written about Celiac Disease.
Bana Jabri
Connection Strength
11.192
Celiac Disease
  1. Transglutaminase 2 Inhibition for Prevention of Mucosal Damage in Celiac Disease. N Engl J Med. 2021 07 01; 385(1):76-77.
    View in: PubMed
    Score: 0.645
  2. Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease. Cell. 2019 02 21; 176(5):967-981.e19.
    View in: PubMed
    Score: 0.546
  3. T Cells in Celiac Disease. J Immunol. 2017 04 15; 198(8):3005-3014.
    View in: PubMed
    Score: 0.482
  4. Cysteinyl leukotrienes mediate lymphokine killer activity induced by NKG2D and IL-15 in cytotoxic T cells during celiac disease. J Exp Med. 2015 Sep 21; 212(10):1487-95.
    View in: PubMed
    Score: 0.430
  5. Novel players in coeliac disease pathogenesis: role of the gut microbiota. Nat Rev Gastroenterol Hepatol. 2015 Sep; 12(9):497-506.
    View in: PubMed
    Score: 0.424
  6. Innate immunity: actuating the gears of celiac disease pathogenesis. Best Pract Res Clin Gastroenterol. 2015 Jun; 29(3):425-35.
    View in: PubMed
    Score: 0.421
  7. IL-15: a central regulator of celiac disease immunopathology. Immunol Rev. 2014 Jul; 260(1):221-34.
    View in: PubMed
    Score: 0.397
  8. How T cells taste gluten in celiac disease. Nat Struct Mol Biol. 2014 May; 21(5):429-31.
    View in: PubMed
    Score: 0.392
  9. Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol. 2013 04; 13(4):294-302.
    View in: PubMed
    Score: 0.363
  10. Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am. 2012 Oct; 22(4):639-60.
    View in: PubMed
    Score: 0.350
  11. Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders. Curr Opin Immunol. 2011 Dec; 23(6):732-8.
    View in: PubMed
    Score: 0.327
  12. Coeliac disease and gluten sensitivity. J Intern Med. 2011 Jun; 269(6):582-90.
    View in: PubMed
    Score: 0.321
  13. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature. 2011 Mar 10; 471(7337):220-4.
    View in: PubMed
    Score: 0.314
  14. Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol. 2009 Dec; 9(12):858-70.
    View in: PubMed
    Score: 0.289
  15. Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15. J Exp Med. 2009 Mar 16; 206(3):707-19.
    View in: PubMed
    Score: 0.274
  16. The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature. 2008 Nov 27; 456(7221):534-8.
    View in: PubMed
    Score: 0.269
  17. Mechanisms of disease: immunopathogenesis of celiac disease. Nat Clin Pract Gastroenterol Hepatol. 2006 Sep; 3(9):516-25.
    View in: PubMed
    Score: 0.231
  18. Reprogramming of CTLs into natural killer-like cells in celiac disease. J Exp Med. 2006 May 15; 203(5):1343-55.
    View in: PubMed
    Score: 0.226
  19. Celiac disease. Annu Rev Med. 2006; 57:207-21.
    View in: PubMed
    Score: 0.220
  20. Is celiac disease an autoimmune disorder? Curr Opin Immunol. 2005 Dec; 17(6):595-600.
    View in: PubMed
    Score: 0.217
  21. Innate and adaptive immunity: the yin and yang of celiac disease. Immunol Rev. 2005 Aug; 206:219-31.
    View in: PubMed
    Score: 0.214
  22. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity. 2004 Sep; 21(3):357-66.
    View in: PubMed
    Score: 0.201
  23. Coeliac disease. Lancet. 2003 Aug 02; 362(9381):383-91.
    View in: PubMed
    Score: 0.186
  24. LRP-1 links post-translational modifications to efficient presentation of celiac disease-specific T cell antigens. Cell Chem Biol. 2023 01 19; 30(1):55-68.e10.
    View in: PubMed
    Score: 0.179
  25. A Mouse Model of Celiac Disease. Curr Protoc. 2022 Aug; 2(8):e515.
    View in: PubMed
    Score: 0.174
  26. Celiac disease and other precursors to small-bowel malignancy. Gastroenterol Clin North Am. 2002 Jun; 31(2):625-39.
    View in: PubMed
    Score: 0.172
  27. An efficient urine peptidomics workflow identifies chemically defined dietary gluten peptides from patients with celiac disease. Nat Commun. 2022 02 16; 13(1):888.
    View in: PubMed
    Score: 0.168
  28. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology. 2000 May; 118(5):867-79.
    View in: PubMed
    Score: 0.149
  29. IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease. Nature. 2020 02; 578(7796):600-604.
    View in: PubMed
    Score: 0.146
  30. Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease. Sci Adv. 2019 08; 5(8):eaaw7756.
    View in: PubMed
    Score: 0.141
  31. Duodenal bacterial proteolytic activity determines sensitivity to dietary antigen through protease-activated receptor-2. Nat Commun. 2019 03 13; 10(1):1198.
    View in: PubMed
    Score: 0.137
  32. Murine Norovirus Infection Induces TH1 Inflammatory Responses to Dietary Antigens. Cell Host Microbe. 2018 11 14; 24(5):677-688.e5.
    View in: PubMed
    Score: 0.134
  33. A viral trigger for celiac disease. PLoS Pathog. 2018 09; 14(9):e1007181.
    View in: PubMed
    Score: 0.133
  34. A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease. Eur J Gastroenterol Hepatol. 2018 08; 30(8):828-837.
    View in: PubMed
    Score: 0.132
  35. P31-43, an undigested gliadin peptide, mimics and enhances the innate immune response to viruses and interferes with endocytic trafficking: a role in celiac disease. Sci Rep. 2018 Jul 17; 8(1):10821.
    View in: PubMed
    Score: 0.131
  36. Human intraepithelial lymphocytes. Mucosal Immunol. 2018 09; 11(5):1281-1289.
    View in: PubMed
    Score: 0.129
  37. Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. Lancet Gastroenterol Hepatol. 2017 07; 2(7):479-493.
    View in: PubMed
    Score: 0.121
  38. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science. 2017 04 07; 356(6333):44-50.
    View in: PubMed
    Score: 0.120
  39. Open-Capsule Budesonide for Refractory Celiac Disease. Am J Gastroenterol. 2017 Jun; 112(6):959-967.
    View in: PubMed
    Score: 0.120
  40. IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction. Nat Rev Immunol. 2015 12; 15(12):771-83.
    View in: PubMed
    Score: 0.109
  41. Intestinal microbiota modulates gluten-induced immunopathology in humanized mice. Am J Pathol. 2015 Nov; 185(11):2969-82.
    View in: PubMed
    Score: 0.108
  42. Distinct and Synergistic Contributions of Epithelial Stress and Adaptive Immunity to Functions of Intraepithelial Killer Cells and Active Celiac Disease. Gastroenterology. 2015 Sep; 149(3):681-91.e10.
    View in: PubMed
    Score: 0.105
  43. Isotretinoin use and celiac disease: a population-based cross-sectional study. Am J Clin Dermatol. 2014 Dec; 15(6):537-42.
    View in: PubMed
    Score: 0.102
  44. Vaccine against autoimmune disease: antigen-specific immunotherapy. Curr Opin Immunol. 2013 Jun; 25(3):410-7.
    View in: PubMed
    Score: 0.091
  45. Intraepithelial lymphocytes in celiac disease immunopathology. Semin Immunopathol. 2012 Jul; 34(4):551-66.
    View in: PubMed
    Score: 0.086
  46. Potential celiac patients: a model of celiac disease pathogenesis. PLoS One. 2011; 6(7):e21281.
    View in: PubMed
    Score: 0.081
  47. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol. 2011; 29:493-525.
    View in: PubMed
    Score: 0.078
  48. Small intestinal CD8+TCRgammadelta+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. J Clin Invest. 2008 Jan; 118(1):281-93.
    View in: PubMed
    Score: 0.063
  49. Relationship of HLA-DQ8 and severity of celiac disease: comparison of New York and Parisian cohorts. Clin Gastroenterol Hepatol. 2004 Oct; 2(10):888-94.
    View in: PubMed
    Score: 0.050
  50. Risk of malignancy in patients with celiac disease. Am J Med. 2003 Aug 15; 115(3):191-5.
    View in: PubMed
    Score: 0.047
  51. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet. 2000 Jul 15; 356(9225):203-8.
    View in: PubMed
    Score: 0.038
  52. Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology. 2000 Jul; 37(1):70-7.
    View in: PubMed
    Score: 0.038
  53. Tissue alarmins and adaptive cytokine induce dynamic and distinct transcriptional responses in tissue-resident intraepithelial cytotoxic T lymphocytes. J Autoimmun. 2020 03; 108:102422.
    View in: PubMed
    Score: 0.037
  54. Identification of a ?c Receptor Antagonist That Prevents Reprogramming of Human Tissue-resident Cytotoxic T Cells by IL15 and IL21. Gastroenterology. 2020 02; 158(3):625-637.e13.
    View in: PubMed
    Score: 0.036
  55. Mechanisms by which gut microorganisms influence food sensitivities. Nat Rev Gastroenterol Hepatol. 2019 01; 16(1):7-18.
    View in: PubMed
    Score: 0.034
  56. Diverse developmental pathways of intestinal intraepithelial lymphocytes. Nat Rev Immunol. 2018 08; 18(8):514-525.
    View in: PubMed
    Score: 0.033
  57. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology. 1998 Mar; 114(3):471-81.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.